Sonendo, Inc.

About Sonendo, Inc.

Sonendo is a medical technology company dedicated to saving teeth from tooth decay, the most prevalent chronic disease globally. Their mission focuses on restoring health through innovative dental solutions.

Products & Services

GentleWave® System:An innovative technology platform designed to treat tooth decay by cleaning and disinfecting microscopic spaces within teeth without removing tooth structure, offering a minimally invasive root canal procedure.

Specialties

Tooth Decay Treatment Minimally Invasive Root Canal Technology Dental Cleaning and Disinfection

Funding History

Debug: View Raw Funding Data

#	Type	Amount Fields	Date Fields	Investors
1	RT: Private Placement T: - FT: Private Placement	A: 5000000 MR: - FA: $5.0 million FAN: 5000000	D: 2025-05-01 FD: 2025-05-01	1 investors

Private Placement Latest

2025-05-01

$5.0M

1 investor (Pro only)

Growth Metrics

+45%

Employee Growth

YoY

3.2x

Funding Growth

Last Round

12

Markets

Operating

10K+

Customers

Active

View 3 more growth metrics with Pro

Unlock All Metrics

Mock Up

Team & Leadership

B

Bjarne Bergheim

Chief Executive Officer and President

J

John Bostjancic

Chief Financial Officer

J

John P. McGaugh

Senior Vice President, Operations

R

Robert Mac Guyatt

Senior Vice President, Marketing

K

Kevin Yein

Vice President, Product Development

A

Anthony P. Bihl III

Chairman of the Board

View 6 more team members with Pro

Unlock Full Team Directory

Recent News

Sonendo, Inc. Announces New Product Launch

2 days ago

Company unveils innovative solution to transform the industry, expanding market reach and capabilities...

Leadership Team Expands with Industry Veteran

1 week ago

New executive brings 20+ years of experience to accelerate growth and strategic initiatives...

Company Recognized as Industry Leader

2 weeks ago

Receives prestigious award for innovation and customer satisfaction in competitive market...

Key Competitors

C1

Competitor Alpha

Series B · $50M raised

C2

Competitor Beta

Series C · $120M raised

C3

Competitor Gamma

Series A · $25M raised

C4

Competitor Delta

Seed · $10M raised